Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
The Vantage Half-Year Review 2018 shows that biopharma small drug developers continue to hold all the cards, while young device makers suffer from a shrinking pool of buyers.
Our report offers analysis and expert commentary on M&A deals, venture financing, initial public offerings and FDA approval in the pharma and medtech sectors during the first half of 2018.